aod9604 human clinical trial weight loss results kg or percent AOD-9604 Results: Week-by-Week Timeline (2026) BioWorld
BioWorld The obesity pipeline: current strategies in the development of anti obesity drugs Nature Reviews Drug Discovery 70 pounds. That's the average weight loss adults with obesity saw on the highest dose of an investigational once weekly Lilly medicine in a new Phase 3 study over 18 months. Nearly PDF] Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans Semantic Scholar
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19


